-+ 0.00%
-+ 0.00%
-+ 0.00%

GENERATE BIOMEDICINES: EXISTING CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES SUFFICIENT TO FUND CURRENT OPERATING PLAN INTO H1 2028

Reuters·08/06/2026 11:00:07

Please log in to view news